期刊文献+

63例胰腺神经内分泌肿瘤的临床特征与预后分析 被引量:4

Analysis of clinical characteristics and prognosis of 63 cases of pancreatic neuroendocrine tumor
暂未订购
导出
摘要 目的:探讨胰腺神经内分泌肿瘤(pancreatic neuroendocrine tumors,PNETs)的发病特点、诊断、治疗及预后的影响因素。方法:回顾性分析2004年8月至2016年8月浙江大学医学院附属邵逸夫医院确诊为PNETs并接受手术治疗的患者63例。收集患者的临床资料,包括年龄、性别、肿瘤功能性、根治性切除等信息,通过单因素、多因素分析的方法求证各因素与预后之间的关系。结果:本研究患者总生存时间(overall survival,OS)为5~127个月,中位生存时间(median overall survival,mOS)为46.6个月。3年及5年生存率分别为88.8%和84.1%。在63例患者中,无功能型占65.1%(41/63),功能型占34.9%(22/63)。单因素分析结果显示淋巴结转移、肝转移、血管侵犯、TNM分期、病理分级以及是否行根治性手术与预后相关(P<0.05)。多因素分析结果并未显示其中存在影响PNETs预后的独立因素。结论:PNETs是一类低度恶性的异质性罕见肿瘤,TNM分期和世界卫生组织(WHO)病理分级能积极指导预后,且淋巴结转移、肝转移、血管侵犯情况对预后有影响。患者经积极手术,尤其是根治性手术可获得较好的预后。 Objective:To investigate the clinical characteristics,diagnosis,treatment,and prognostic factors of pancreatic neuroendocrine neoplasms(PNENs).Methods:From August 2004 to August 2016,the clinical data of 63 patients with PNENs in the Sir Run Run Shaw Hospital,an affiliate of the Zhejiang University School of Medicine,were retrospectively analyzed.The data included age,gender,function,tumor location,tumor size,pathological characteristics,lymph nodes,metastasis,and treatment.Association of these factors with PNEN prognosis was proven by univariate analysis and multivariate analysis.Results:In our study,the patients' overall survival time was between 5 and 127 months;the median time was about 46.6 months.Moreover,the survival rates in three years and five years are 88.8% and 84.1% respectively.Univariate analysis showed that factors such as lymph node metastasis,liver metastasis,vascular invasion,TNM staging and pathological grading,and radical operation were associated with prognosis(P〈0.05).We did not prove any of the factors to be an independent factor associated with poor short-term outcome by multivariate analysis.Conclusion:PNENs are rare low-grade malignant tumors with heterogeneity,which is why they can be erroneously diagnosed.AJCC TNM staging in 2017 and the WHO pathological classification in 2010 can actively guide the prognosis evaluation.The lymph node metastasis,liver metastasis,and vascular invasion affected the prognosis of PNENs.Patients with radical operation had improved prognosis.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2017年第16期810-815,共6页 Chinese Journal of Clinical Oncology
基金 浙江省科技厅重点研发计划项目(编号:2015C03G2010160) 浙江省自然科学基金项目(编号:LY17H160015)资助~~
关键词 胰腺神经内分泌肿瘤 临床表现 诊断 治疗 预后 pancreatic neuroendocrine tumors, clinical characteristics, diagnosis, treatment, prognosis
  • 相关文献

参考文献1

二级参考文献54

  • 1Pierre Goudet,Arnaud Murat,Christine Binquet,Christine Cardot-Bauters,Annie Costa,Philippe Ruszniewski,Patricia Niccoli,Fabrice Ménégaux,Georges Chabrier,Fran?oise Borson-Chazot,Antoine Tabarin,Philippe Bouchard,Brigitte Delemer,Alfred Beckers,Claire Bonithon-Kopp.Risk Factors and Causes of Death in MEN1 Disease. A GTE (Groupe d’Etude des Tumeurs Endocrines) Cohort Study Among 758 Patients[J]. World Journal of Surgery . 2010 (2)
  • 2Tetsuhide Ito,Hironobu Sasano,Masao Tanaka,R. Yoshiyuki Osamura,Iwao Sasaki,Wataru Kimura,Koji Takano,Takao Obara,Miyuki Ishibashi,Kazuwa Nakao,Ryuichiro Doi,Akira Shimatsu,Toshirou Nishida,Izumi Komoto,Yukio Hirata,Kazuhiko Nakamura,Hisato Igarashi,Robert T. Jensen,Bertram Wiedenmann,Masayuki Imamura.Epidemiological study of gastroenteropancreatic neuroendocrine tumors in Japan[J]. Journal of Gastroenterology . 2010 (2)
  • 3Günter Kl?ppel,Martin Anlauf,Aurel Perren.Endocrine Precursor Lesions of Gastroenteropancreatic Neuroendocrine Tumors[J]. Endocrine Pathology . 2007 (3)
  • 4Tetsuhide Ito,Masao Tanaka,Hironobu Sasano,Yoshiyuki R. Osamura,Iwao Sasaki,Wataru Kimura,Koji Takano,Takao Obara,Miyuki Ishibashi,Kazuwa Nakao,Ryuichiro Doi,Akira Shimatsu,Toshirou Nishida,Izumi Komoto,Yukio Hirata,Masayuki Imamura,Ken Kawabe,Kazuhiko Nakamura.Preliminary results of a Japanese nationwide survey of neuroendocrine gastrointestinal tumors[J]. Journal of Gastroenterology . 2007 (6)
  • 5Guida Maria Portela-Gomes,Mats Stridsberg,Lars Grimelius,Otto Rorstad,Eva Tiensuu Janson.Differential Expression of the Five Somatostatin Receptor Subtypes in Human Benign and Malignant Insulinomas – Predominance of Receptor Subtype 4[J]. Endocrine Pathology . 2007 (2)
  • 6Masayuki Imamura MD,Izumi Komoto MD,Shuichi Ota MD.Changing Treatment Strategy for Gastrinoma in Patients with Zollinger-Ellison Syndrome[J]. World Journal of Surgery . 2006 (1)
  • 7Masayuki Imamura M.D.,Izumi Komoto M.D.,Ryuichiro Doi M.D.,Hisashi Onodera M.D.,Hiroyuki Kobayashi M.D.,Yasuhiro Kawai M.D..New Pancreas-preserving Total Duodenectomy Technique[J]. World Journal of Surgery . 2005 (2)
  • 8Masayuki Kato,Masayuki Imamura,Ryo Hosotani,Yutaka Shimada,Ryuichiro Doi,Atsushi Itami,Izumi Komoto,Tadako Kosaka,Junji Konishi.Curative Resection of Microgastrinomas Based on the Intraoperative Secretin Test[J]. World Journal of Surgery . 2000 (11)
  • 9Masayuki Imamura,Yutaka Shimada,Masayuki Kato,Ryuichirou Doi,Noriyuki Okada,Mituaki Hashimoto.Usefulness of selective arterial calcium injection test and secretin test in patients with insulinoma[J]. Journal of Hepato - Biliary - Pancreatic Surgery . 1994 (5)
  • 10Diarmuid S. O’Riordain M.B.,Timothy O’Brien M.B.,Jon A. Heerden M.B.,F. J. Service M.D., Ph.D.,Clive S. Grant M.D..Surgical management of insulinoma associated with multiple endocrine neoplasia type I[J]. World Journal of Surgery . 1994 (4)

共引文献9

同被引文献21

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部